Progress in developing transgenic monkey model for Huntington’s disease

go back to reference Aggarwal M, Duan W, Hou Z, Rakesh N, Peng Q, Ross CA, Miller MI, Mori S, Zhang J (2012) Spatiotemporal mapping of brain atrophy in mouse models of Huntington’s disease using longitudinal in vivo magnetic resonance imaging. Neuroimage 60(4):2086–2095. doi:10.1016/j.neuroimage.2012.01.141 PubMedPubMedCentralCrossRef Aggarwal M, Duan W, Hou Z, Rakesh N, Peng Q, Ross CA, Miller MI, Mori S, Zhang J (2012) Spatiotemporal mapping of brain atrophy in mouse models of Huntington’s disease using longitudinal in vivo magnetic resonance imaging. Neuroimage 60(4):2086–2095. doi:10.​1016/​j.​neuroimage.​2012.​01.​141 PubMedPubMedCentralCrossRef

go back to reference Akopian G, Barry J, Cepeda C, Levine MS (2016) Altered membrane properties and firing patterns of external globus pallidus neurons in the R6/2 mouse model of Huntington’s disease. J Neurosci Res 94(12):1400–1410. doi:10.1002/jnr.23889 PubMedPubMedCentralCrossRef Akopian G, Barry J, Cepeda C, Levine MS (2016) Altered membrane properties and firing patterns of external globus pallidus neurons in the R6/2 mouse model of Huntington’s disease. J Neurosci Res 94(12):1400–1410. doi:10.​1002/​jnr.​23889 PubMedPubMedCentralCrossRef

go back to reference Alexandrov V, Brunner D, Menalled LB, Kudwa A, Watson-Johnson J, Mazzella M, Russell I, Ruiz MC, Torello J, Sabath E, Sanchez A, Gomez M, Filipov I, Cox K, Kwan M, Ghavami A, Ramboz S, Lager B, Wheeler VC, Aaronson J, Rosinski J, Gusella JF, MacDonald ME, Howland D, Kwak S (2016) Large-scale phenome analysis defines a behavioral signature for Huntington’s disease genotype in mice. Nat Biotechnol 34(8):838–844. doi:10.1038/nbt.3587 PubMedCrossRef Alexandrov V, Brunner D, Menalled LB, Kudwa A, Watson-Johnson J, Mazzella M, Russell I, Ruiz MC, Torello J, Sabath E, Sanchez A, Gomez M, Filipov I, Cox K, Kwan M, Ghavami A, Ramboz S, Lager B, Wheeler VC, Aaronson J, Rosinski J, Gusella JF, MacDonald ME, Howland D, Kwak S (2016) Large-scale phenome analysis defines a behavioral signature for Huntington’s disease genotype in mice. Nat Biotechnol 34(8):838–844. doi:10.​1038/​nbt.​3587 PubMedCrossRef

go back to reference Alzheimer A (1911) Uber die anatomische Grundlage der Huntington’schen Chorea und der choreaischen Bewegung uberhaupt. Neurol Centralblatt 30:891–892 Alzheimer A (1911) Uber die anatomische Grundlage der Huntington’schen Chorea und der choreaischen Bewegung uberhaupt. Neurol Centralblatt 30:891–892

go back to reference Ament SA, Pearl JR, Grindeland A, St Claire J, Earls JC, Kovalenko M, Gillis T, Mysore J, Gusella JF, Lee JM, Kwak S, Howland D, Lee MY, Baxter D, Scherler K, Wang K, Geman D, Carroll JB, MacDonald ME, Carlson G, Wheeler VC, Price ND, Hood LE (2017) High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington’s disease CAG knock-in mice across multiple genetic backgrounds. Hum Mol Genet 26(5):913–922. doi:10.1093/hmg/ddx0063045004 PubMedCrossRef Ament SA, Pearl JR, Grindeland A, St Claire J, Earls JC, Kovalenko M, Gillis T, Mysore J, Gusella JF, Lee JM, Kwak S, Howland D, Lee MY, Baxter D, Scherler K, Wang K, Geman D, Carroll JB, MacDonald ME, Carlson G, Wheeler VC, Price ND, Hood LE (2017) High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington’s disease CAG knock-in mice across multiple genetic backgrounds. Hum Mol Genet 26(5):913–922. doi:10.​1093/​hmg/​ddx0063045004 PubMedCrossRef

go back to reference An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM (2012) Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11(2):253–263. doi:10.1016/j.stem.2012.04.026 PubMedPubMedCentralCrossRef An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM (2012) Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11(2):253–263. doi:10.​1016/​j.​stem.​2012.​04.​026 PubMedPubMedCentralCrossRef

go back to reference Aosaki T, Tsubokawa H, Ishida A, Watanabe K, Graybiel AM, Kimura M (1994) Responses of tonically active neurons in the primate’s striatum undergo systematic changes during behavioral sensorimotor conditioning. J Neurosci 14(6):3969–3984PubMed Aosaki T, Tsubokawa H, Ishida A, Watanabe K, Graybiel AM, Kimura M (1994) Responses of tonically active neurons in the primate’s striatum undergo systematic changes during behavioral sensorimotor conditioning. J Neurosci 14(6):3969–3984PubMed

go back to reference Apicella P (2007) Leading tonically active neurons of the striatum from reward detection to context recognition. Trends Neurosci 30(6):299–306. doi:10.1016/j.tins.2007.03.011 PubMedCrossRef Apicella P (2007) Leading tonically active neurons of the striatum from reward detection to context recognition. Trends Neurosci 30(6):299–306. doi:10.​1016/​j.​tins.​2007.​03.​011 PubMedCrossRef

go back to reference Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005. doi:10.1038/nrdp.2015.5 PubMedCrossRef Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005. doi:10.​1038/​nrdp.​2015.​5 PubMedCrossRef

go back to reference Beglinger LJ, Duff K, Allison J, Theriault D, O’Rourke JJ, Leserman A, Paulsen JS (2010) Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol 32(6):573–578. doi:10.1080/13803390903313564 PubMedCrossRef Beglinger LJ, Duff K, Allison J, Theriault D, O’Rourke JJ, Leserman A, Paulsen JS (2010) Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol 32(6):573–578. doi:10.​1080/​1380339090331356​4 PubMedCrossRef

go back to reference Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 5(4):382–389PubMedCrossRef Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 5(4):382–389PubMedCrossRef

go back to reference Berrios GE, Wagle AC, Markova IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, Bak T, Hodges JR (2001) Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington’s disease gene carriers. Psychiatry Res 102(3):217–225PubMedCrossRef Berrios GE, Wagle AC, Markova IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, Bak T, Hodges JR (2001) Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington’s disease gene carriers. Psychiatry Res 102(3):217–225PubMedCrossRef

go back to reference Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, Lu W, McCusker E, Mills JA, Raymond LA, Testa C, Wojcieszek J, Paulsen JS (2013) Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci 5:12. doi:10.3389/fnagi.2013.00012 PubMedPubMedCentralCrossRef Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, Lu W, McCusker E, Mills JA, Raymond LA, Testa C, Wojcieszek J, Paulsen JS (2013) Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci 5:12. doi:10.​3389/​fnagi.​2013.​00012 PubMedPubMedCentralCrossRef

go back to reference Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, Moller T, Tabrizi SJ (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med 205(8):1869–1877. doi:10.1084/jem.20080178jem.20080178 PubMedPubMedCentralCrossRef Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, Moller T, Tabrizi SJ (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med 205(8):1869–1877. doi:10.​1084/​jem.​20080178jem.​20080178 PubMedPubMedCentralCrossRef

go back to reference Bouwens JA, van Duijn E, van der Mast RC, Roos RA, Giltay EJ (2015) Irritability in a prospective cohort of Huntington’s disease mutation carriers. J Neuropsychiatry Clin Neurosci 27(3):206–212. doi:10.1176/appi.neuropsych.14030051 PubMedCrossRef Bouwens JA, van Duijn E, van der Mast RC, Roos RA, Giltay EJ (2015) Irritability in a prospective cohort of Huntington’s disease mutation carriers. J Neuropsychiatry Clin Neurosci 27(3):206–212. doi:10.​1176/​appi.​neuropsych.​14030051 PubMedCrossRef

go back to reference Canales JJ, Graybiel AM (2000) A measure of striatal function predicts motor stereotypy. Nat Neurosci 3(4):377–383. doi:10.1038/73949 PubMedCrossRef Canales JJ, Graybiel AM (2000) A measure of striatal function predicts motor stereotypy. Nat Neurosci 3(4):377–383. doi:10.​1038/​73949 PubMedCrossRef

go back to reference Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation. J Neurosci 19(8):3248–3257PubMed Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation. J Neurosci 19(8):3248–3257PubMed

go back to reference Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K, Yang J, Huang AH, Parnpai R, Chan AW (2014) Reversal of cellular phenotypes in neural cells derived from Huntington’s disease monkey-induced pluripotent stem cells. Stem Cell Rep 3(4):585–593. doi:10.1016/j.stemcr.2014.07.011 CrossRef Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K, Yang J, Huang AH, Parnpai R, Chan AW (2014) Reversal of cellular phenotypes in neural cells derived from Huntington’s disease monkey-induced pluripotent stem cells. Stem Cell Rep 3(4):585–593. doi:10.​1016/​j.​stemcr.​2014.​07.​011 CrossRef

go back to reference Cepeda C, Galvan L, Holley SM, Rao SP, Andre VM, Botelho EP, Chen JY, Watson JB, Deisseroth K, Levine MS (2013) Multiple sources of striatal inhibition are differentially affected in Huntington’s disease mouse models. J Neurosci 33(17):7393–7406. doi:10.1523/JNEUROSCI.2137-12.2013 PubMedPubMedCentralCrossRef Cepeda C, Galvan L, Holley SM, Rao SP, Andre VM, Botelho EP, Chen JY, Watson JB, Deisseroth K, Levine MS (2013) Multiple sources of striatal inhibition are differentially affected in Huntington’s disease mouse models. J Neurosci 33(17):7393–7406. doi:10.​1523/​JNEUROSCI.​2137-12.​2013 PubMedPubMedCentralCrossRef

go back to reference Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K, Neumann A, Cheng H, Li C, Nelson K, Banta H, Zola SM, Villinger F, Yang J, Testa CM, Mao H, Zhang X, Bachevalier J (2014) A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci 15:36. doi:10.1186/1471-2202-15-361471-2202-15-36 PubMedPubMedCentralCrossRef Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K, Neumann A, Cheng H, Li C, Nelson K, Banta H, Zola SM, Villinger F, Yang J, Testa CM, Mao H, Zhang X, Bachevalier J (2014) A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci 15:36. doi:10.​1186/​1471-2202-15-361471-2202-15-36 PubMedPubMedCentralCrossRef

go back to reference Chan AW, Jiang J, Chen Y, Li C, Prucha MS, Hu Y, Chi T, Moran S, Rahim T, Li S, Li X, Zola SM, Testa CM, Mao H, Villalba R, Smith Y, Zhang X, Bachevalier J (2015) Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood. PLoS One 10(5):e0122335. doi:10.1371/journal.pone.0122335 PubMedPubMedCentralCrossRef Chan AW, Jiang J, Chen Y, Li C, Prucha MS, Hu Y, Chi T, Moran S, Rahim T, Li S, Li X, Zola SM, Testa CM, Mao H, Villalba R, Smith Y, Zhang X, Bachevalier J (2015) Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood. PLoS One 10(5):e0122335. doi:10.​1371/​journal.​pone.​0122335 PubMedPubMedCentralCrossRef

go back to reference Ciamei A, Detloff PJ, Morton AJ (2015) Progression of behavioural despair in R6/2 and Hdh knock-in mouse models recapitulates depression in Huntington’s disease. Behav Brain Res 291:140–146. doi:10.1016/j.bbr.2015.05.010 PubMedCrossRef Ciamei A, Detloff PJ, Morton AJ (2015) Progression of behavioural despair in R6/2 and Hdh knock-in mouse models recapitulates depression in Huntington’s disease. Behav Brain Res 291:140–146. doi:10.​1016/​j.​bbr.​2015.​05.​010 PubMedCrossRef

go back to reference Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS Jr, Helmers SL, Factor SA, Jones R, Testa CM (2012) Seizures in juvenile Huntington’s disease: frequency and characterization in a multicenter cohort. Mov Disord 27(14):1797–1800. doi:10.1002/mds.25237 PubMedCrossRef Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS Jr, Helmers SL, Factor SA, Jones R, Testa CM (2012) Seizures in juvenile Huntington’s disease: frequency and characterization in a multicenter cohort. Mov Disord 27(14):1797–1800. doi:10.​1002/​mds.​25237 PubMedCrossRef

go back to reference Crook ZR, Housman D (2011) Huntington’s disease: can mice lead the way to treatment? Neuron 69(3):423–435. doi:10.1016/j.neuron.2010.12.035 PubMedPubMedCentralCrossRef Crook ZR, Housman D (2011) Huntington’s disease: can mice lead the way to treatment? Neuron 69(3):423–435. doi:10.​1016/​j.​neuron.​2010.​12.​035 PubMedPubMedCentralCrossRef

go back to reference Crook ZR, Housman DE (2013) Surveying the landscape of Huntington’s disease mechanisms, measurements, and medicines. J Huntingtons Dis 2(4):405–436. doi:10.3233/JHD-130072 PubMed Crook ZR, Housman DE (2013) Surveying the landscape of Huntington’s disease mechanisms, measurements, and medicines. J Huntingtons Dis 2(4):405–436. doi:10.​3233/​JHD-130072 PubMed

go back to reference Dale M, van Duijn E (2015) Anxiety in Huntington’s disease. J Neuropsychiatry Clin Neurosci 27(4):262–271. doi:10.1176/appi.neuropsych.14100265 PubMedCrossRef Dale M, van Duijn E (2015) Anxiety in Huntington’s disease. J Neuropsychiatry Clin Neurosci 27(4):262–271. doi:10.​1176/​appi.​neuropsych.​14100265 PubMedCrossRef

go back to reference Davies S, Ramsden DB (2001) Huntington’s disease. Mol Pathol 54(6):409–413PubMedPubMedCentralCrossRef Davies S, Ramsden DB (2001) Huntington’s disease. Mol Pathol 54(6):409–413PubMedPubMedCentralCrossRef

go back to reference Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90(3):537–548PubMedCrossRef Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90(3):537–548PubMedCrossRef

go back to reference DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13(7):281–285PubMedCrossRef DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13(7):281–285PubMedCrossRef

go back to reference Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A (2004) Differential loss of striatal projection systems in Huntington’s disease: a quantitative immunohistochemical study. J Chem Neuroanat 27(3):143–164. doi:10.1016/j.jchemneu.2004.02.005 PubMedCrossRef Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A (2004) Differential loss of striatal projection systems in Huntington’s disease: a quantitative immunohistochemical study. J Chem Neuroanat 27(3):143–164. doi:10.​1016/​j.​jchemneu.​2004.​02.​005 PubMedCrossRef

go back to reference Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington’s disease. J Med Genet 30(4):293–295PubMedPubMedCentralCrossRef Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington’s disease. J Med Genet 30(4):293–295PubMedPubMedCentralCrossRef

go back to reference DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990–1993PubMedCrossRef DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990–1993PubMedCrossRef

go back to reference Dong G, Gross K, Qiao F, Ferguson J, Callegari EA, Rezvani K, Zhang D, Gloeckner CJ, Ueffing M, Wang H (2012) Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity. J Neurochem 123(3):437–446. doi:10.1111/j.1471-4159.2012.07919.x PubMedCrossRef Dong G, Gross K, Qiao F, Ferguson J, Callegari EA, Rezvani K, Zhang D, Gloeckner CJ, Ueffing M, Wang H (2012) Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity. J Neurochem 123(3):437–446. doi:10.​1111/​j.​1471-4159.​2012.​07919.​x PubMedCrossRef

go back to reference Duff K, Beglinger LJ, Theriault D, Allison J, Paulsen JS (2010) Cognitive deficits in Huntington’s disease on the Repeatable Battery for the Assessment of Neuropsychological Status. J Clin Exp Neuropsychol 32(3):231–238. doi:10.1080/13803390902926184 PubMedCrossRef Duff K, Beglinger LJ, Theriault D, Allison J, Paulsen JS (2010) Cognitive deficits in Huntington’s disease on the Repeatable Battery for the Assessment of Neuropsychological Status. J Clin Exp Neuropsychol 32(3):231–238. doi:10.​1080/​1380339090292618​4 PubMedCrossRef

go back to reference Dumas EM, van den Bogaard SJ, Hart EP, Soeter RP, van Buchem MA, van der Grond J, Rombouts SA, Roos RA (2013) Reduced functional brain connectivity prior to and after disease onset in Huntington’s disease. Neuroimage Clin 2:377–384. doi:10.1016/j.nicl.2013.03.001 PubMedPubMedCentralCrossRef Dumas EM, van den Bogaard SJ, Hart EP, Soeter RP, van Buchem MA, van der Grond J, Rombouts SA, Roos RA (2013) Reduced functional brain connectivity prior to and after disease onset in Huntington’s disease. Neuroimage Clin 2:377–384. doi:10.​1016/​j.​nicl.​2013.​03.​001 PubMedPubMedCentralCrossRef

go back to reference Figueredo-Cardenas G, Morello M, Sancesario G, Bernardi G, Reiner A (1996) Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res 735(2):317–324PubMedCrossRef Figueredo-Cardenas G, Morello M, Sancesario G, Bernardi G, Reiner A (1996) Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res 735(2):317–324PubMedCrossRef

go back to reference Fink KD, Rossignol J, Crane AT, Davis KK, Bombard MC, Bavar AM, Clerc S, Lowrance SA, Song C, Lescaudron L, Dunbar GL (2013) Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis. Stem Cell Res Ther 4(5):130. doi:10.1186/scrt341scrt341 PubMedPubMedCentralCrossRef Fink KD, Rossignol J, Crane AT, Davis KK, Bombard MC, Bavar AM, Clerc S, Lowrance SA, Song C, Lescaudron L, Dunbar GL (2013) Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis. Stem Cell Res Ther 4(5):130. doi:10.​1186/​scrt341scrt341 PubMedPubMedCentralCrossRef

go back to reference Folstein S, Abbott MH, Chase GA, Jensen BA, Folstein MF (1983) The association of affective disorder with Huntington’s disease in a case series and in families. Psychol Med 13(3):537–542PubMedCrossRef Folstein S, Abbott MH, Chase GA, Jensen BA, Folstein MF (1983) The association of affective disorder with Huntington’s disease in a case series and in families. Psychol Med 13(3):537–542PubMedCrossRef

go back to reference Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG (2010) Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington’s disease. J Neurochem 112(1):112–122. doi:10.1111/j.1471-4159.2009.06442.x PubMedCrossRef Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG (2010) Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington’s disease. J Neurochem 112(1):112–122. doi:10.​1111/​j.​1471-4159.​2009.​06442.​x PubMedCrossRef

go back to reference Freeze BS, Kravitz AV, Hammack N, Berke JD, Kreitzer AC (2013) Control of basal ganglia output by direct and indirect pathway projection neurons. J Neurosci 33(47):18531–18539. doi:10.1523/JNEUROSCI.1278-13.2013 PubMedPubMedCentralCrossRef Freeze BS, Kravitz AV, Hammack N, Berke JD, Kreitzer AC (2013) Control of basal ganglia output by direct and indirect pathway projection neurons. J Neurosci 33(47):18531–18539. doi:10.​1523/​JNEUROSCI.​1278-13.​2013 PubMedPubMedCentralCrossRef

go back to reference Fujiyama F, Sohn J, Nakano T, Furuta T, Nakamura KC, Matsuda W, Kaneko T (2011) Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci 33(4):668–677. doi:10.1111/j.1460-9568.2010.07564.x PubMedCrossRef Fujiyama F, Sohn J, Nakano T, Furuta T, Nakamura KC, Matsuda W, Kaneko T (2011) Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci 33(4):668–677. doi:10.​1111/​j.​1460-9568.​2010.​07564.​x PubMedCrossRef

go back to reference Geevasinga N, Richards FH, Jones KJ, Ryan MM (2006) Juvenile Huntington disease. J Paediatr Child Health 42(9):552–554. doi:10.1111/j.1440-1754.2006.00921.x PubMedCrossRef Geevasinga N, Richards FH, Jones KJ, Ryan MM (2006) Juvenile Huntington disease. J Paediatr Child Health 42(9):552–554. doi:10.​1111/​j.​1440-1754.​2006.​00921.​x PubMedCrossRef

go back to reference Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington’s disease. Eur J Neurosci 27(11):2803–2820. doi:10.1111/j.1460-9568.2008.06310.x PubMedCrossRef Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington’s disease. Eur J Neurosci 27(11):2803–2820. doi:10.​1111/​j.​1460-9568.​2008.​06310.​x PubMedCrossRef

go back to reference Graveland GA, DiFiglia M (1985) The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res 327(1–2):307–311PubMedCrossRef Graveland GA, DiFiglia M (1985) The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res 327(1–2):307–311PubMedCrossRef

go back to reference Graveland GA, Williams RS, DiFiglia M (1985) A Golgi study of the human neostriatum: neurons and afferent fibers. J Comp Neurol 234(3):317–333. doi:10.1002/cne.902340304 PubMedCrossRef Graveland GA, Williams RS, DiFiglia M (1985) A Golgi study of the human neostriatum: neurons and afferent fibers. J Comp Neurol 234(3):317–333. doi:10.​1002/​cne.​902340304 PubMedCrossRef

go back to reference Graybiel AM, Ragsdale CW Jr (1978) Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci USA 75(11):5723–5726PubMedPubMedCentralCrossRef Graybiel AM, Ragsdale CW Jr (1978) Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci USA 75(11):5723–5726PubMedPubMedCentralCrossRef

go back to reference Gupta S, Jie S, Colby DW (2012) Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay. J Biol Chem 287(13):9982–9989. doi:10.1074/jbc.M111.305417 PubMedCrossRef Gupta S, Jie S, Colby DW (2012) Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay. J Biol Chem 287(13):9982–9989. doi:10.​1074/​jbc.​M111.​305417 PubMedCrossRef

go back to reference Hauser MD (1991) Sources of acoustic variation in rhesus macaque (Macaca mulatta) vocalizations. Ethology 89:29–46CrossRef Hauser MD (1991) Sources of acoustic variation in rhesus macaque (Macaca mulatta) vocalizations. Ethology 89:29–46CrossRef

go back to reference Hewitt W (1961) The development of the human internal capsule and lentiform nucleus. J Anat 95:191–199PubMedPubMedCentral Hewitt W (1961) The development of the human internal capsule and lentiform nucleus. J Anat 95:191–199PubMedPubMedCentral

go back to reference Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T (2003) Profile of cognitive progression in early Huntington’s disease. Neurology 61(12):1702–1706PubMedCrossRef Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T (2003) Profile of cognitive progression in early Huntington’s disease. Neurology 61(12):1702–1706PubMedCrossRef

go back to reference Holter SM, Stromberg M, Kovalenko M, Garrett L, Glasl L, Lopez E, Guide J, Gotz A, Hans W, Becker L, Rathkolb B, Rozman J, Schrewed A, Klingenspor M, Klopstock T, Schulz H, Wolf E, Wursta W, Gillis T, Wakimoto H, Seidman J, MacDonald ME, Cotman S, Gailus-Durner V, Fuchs H, de Angelis MH, Lee JM, Wheeler VC (2013) A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington’s disease CAG knock-in mice. PLoS One 8(11):e80923. doi:10.1371/journal.pone.0080923 PubMedPubMedCentralCrossRef Holter SM, Stromberg M, Kovalenko M, Garrett L, Glasl L, Lopez E, Guide J, Gotz A, Hans W, Becker L, Rathkolb B, Rozman J, Schrewed A, Klingenspor M, Klopstock T, Schulz H, Wolf E, Wursta W, Gillis T, Wakimoto H, Seidman J, MacDonald ME, Cotman S, Gailus-Durner V, Fuchs H, de Angelis MH, Lee JM, Wheeler VC (2013) A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington’s disease CAG knock-in mice. PLoS One 8(11):e80923. doi:10.​1371/​journal.​pone.​0080923 PubMedPubMedCentralCrossRef

go back to reference Howland DS, Munoz-Sanjuan I (2014) Mind the gap: models in multiple species needed for therapeutic development in Huntington’s disease. Mov Disord 29(11):1397–1403. doi:10.1002/mds.26008 PubMedCrossRef Howland DS, Munoz-Sanjuan I (2014) Mind the gap: models in multiple species needed for therapeutic development in Huntington’s disease. Mov Disord 29(11):1397–1403. doi:10.​1002/​mds.​26008 PubMedCrossRef

go back to reference Hu H, Gan J, Jonas P (2014) Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science 345(6196):1255263. doi:10.1126/science.1255263 PubMedCrossRef Hu H, Gan J, Jonas P (2014) Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science 345(6196):1255263. doi:10.​1126/​science.​1255263 PubMedCrossRef

go back to reference Huntington G (1872) On chorea. Med Surg Rep 26:317–321 Huntington G (1872) On chorea. Med Surg Rep 26:317–321

go back to reference Jelgersma G (1908) Uber anatomische Befunde bei Paralyis agitans und bei chronischer Chorea. Neurol Contralblatt 27:995–996 Jelgersma G (1908) Uber anatomische Befunde bei Paralyis agitans und bei chronischer Chorea. Neurol Contralblatt 27:995–996

go back to reference Jennings CG, Landman R, Zhou Y, Sharma J, Hyman J, Movshon JA, Qiu Z, Roberts AC, Roe AW, Wang X, Zhou H, Wang L, Zhang F, Desimone R, Feng G (2016) Opportunities and challenges in modeling human brain disorders in transgenic primates. Nat Neurosci 19(9):1123–1130. doi:10.1038/nn.4362nn.4362 PubMedCrossRef Jennings CG, Landman R, Zhou Y, Sharma J, Hyman J, Movshon JA, Qiu Z, Roberts AC, Roe AW, Wang X, Zhou H, Wang L, Zhang F, Desimone R, Feng G (2016) Opportunities and challenges in modeling human brain disorders in transgenic primates. Nat Neurosci 19(9):1123–1130. doi:10.​1038/​nn.​4362nn.​4362 PubMedCrossRef

go back to reference Kalin NH, Shelton SE (1998) Ontogeny and stability of separation and threat-induced defensive behaviors in rhesus monkeys during the first year of life. Am J Primatol 44(2):125–135. doi:10.1002/(SICI)1098-2345(1998)44:2<125:AID-AJP3>3.0.CO;2-Y PubMedCrossRef Kalin NH, Shelton SE (1998) Ontogeny and stability of separation and threat-induced defensive behaviors in rhesus monkeys during the first year of life. Am J Primatol 44(2):125–135. doi:10.​1002/​(SICI)1098-2345(1998)44:​2<125:​AID-AJP3>3.​0.​CO;2-Y PubMedCrossRef

go back to reference Kawaguchi Y, Wilson CJ, Emson PC (1989) Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol 62(5):1052–1068PubMedCrossRef Kawaguchi Y, Wilson CJ, Emson PC (1989) Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol 62(5):1052–1068PubMedCrossRef

go back to reference Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18(12):527–535PubMedCrossRef Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18(12):527–535PubMedCrossRef

go back to reference Killoran A, Biglan KM (2012) Therapeutics in Huntington’s disease. Curr Treat Options Neurol. doi:10.1007/s11940-012-0165-x PubMed Killoran A, Biglan KM (2012) Therapeutics in Huntington’s disease. Curr Treat Options Neurol. doi:10.​1007/​s11940-012-0165-x PubMed

go back to reference Kincaid AE, Wilson CJ (1996) Corticostriatal innervation of the patch and matrix in the rat neostriatum. J Comp Neurol 374(4):578–592. doi:10.1002/(SICI)1096-9861(19961028)374:4<578:AID-CNE7>3.0.CO;2-Z PubMedCrossRef Kincaid AE, Wilson CJ (1996) Corticostriatal innervation of the patch and matrix in the rat neostriatum. J Comp Neurol 374(4):578–592. doi:10.​1002/​(SICI)1096-9861(19961028)374:​4<578:​AID-CNE7>3.​0.​CO;2-Z PubMedCrossRef

go back to reference Kocerha J, Liu Y, Willoughby D, Chidamparam K, Benito J, Nelson K, Xu Y, Chi T, Engelhardt H, Moran S, Yang SH, Li SH, Li XJ, Larkin K, Neumann A, Banta H, Yang JJ, Chan AW (2013) Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys. BMC Neurosci 14:88. doi:10.1186/1471-2202-14-88 PubMedPubMedCentralCrossRef Kocerha J, Liu Y, Willoughby D, Chidamparam K, Benito J, Nelson K, Xu Y, Chi T, Engelhardt H, Moran S, Yang SH, Li SH, Li XJ, Larkin K, Neumann A, Banta H, Yang JJ, Chan AW (2013) Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys. BMC Neurosci 14:88. doi:10.​1186/​1471-2202-14-88 PubMedPubMedCentralCrossRef

go back to reference Kumar A, Zhang J, Tallaksen-Greene S, Crowley MR, Crossman DK, Morton AJ, Van Groen T, Kadish I, Albin RL, Lesort M, Detloff PJ (2016) Allelic series of Huntington’s disease knock-in mice reveals expression discorrelates. Hum Mol Genet 25(8):1619–1636. doi:10.1093/hmg/ddw040 PubMedPubMedCentralCrossRef Kumar A, Zhang J, Tallaksen-Greene S, Crowley MR, Crossman DK, Morton AJ, Van Groen T, Kadish I, Albin RL, Lesort M, Detloff PJ (2016) Allelic series of Huntington’s disease knock-in mice reveals expression discorrelates. Hum Mol Genet 25(8):1619–1636. doi:10.​1093/​hmg/​ddw040 PubMedPubMedCentralCrossRef

go back to reference Kunkanjanawan T, Carter RL, Prucha MS, Yang J, Parnpai R, Chan AW (2016) miR-196a ameliorates cytotoxicity and cellular phenotype in transgenic Huntington’s disease monkey neural cells. PLoS One 11(9):e0162788. doi:10.1371/journal.pone.0162788 PubMedPubMedCentralCrossRef Kunkanjanawan T, Carter RL, Prucha MS, Yang J, Parnpai R, Chan AW (2016) miR-196a ameliorates cytotoxicity and cellular phenotype in transgenic Huntington’s disease monkey neural cells. PLoS One 11(9):e0162788. doi:10.​1371/​journal.​pone.​0162788 PubMedPubMedCentralCrossRef

go back to reference Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington’s disease. J Neurosci 21(23):9112–9123PubMed Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington’s disease. J Neurosci 21(23):9112–9123PubMed

go back to reference Lanciego JL, Luquin N, Obeso JA (2012) Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med 2(12):a009621. doi:10.1101/cshperspect.a009621a009621 PubMedPubMedCentralCrossRef Lanciego JL, Luquin N, Obeso JA (2012) Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med 2(12):a009621. doi:10.​1101/​cshperspect.​a009621a009621 PubMedPubMedCentralCrossRef

go back to reference Langbehn DR, Hayden MR, Paulsen JS (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B(2):397–408. doi:10.1002/ajmg.b.30992 PubMedPubMedCentralCrossRef Langbehn DR, Hayden MR, Paulsen JS (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B(2):397–408. doi:10.​1002/​ajmg.​b.​30992 PubMedPubMedCentralCrossRef

go back to reference Lange HW, Aulich A (1986) Die Hirnatrophie bei der Huntingtonschen Keankheit. In: Die Huntingtonsche Krankheit. Hippokrates, Stuttgart, pp 25–41 Lange HW, Aulich A (1986) Die Hirnatrophie bei der Huntingtonschen Keankheit. In: Die Huntingtonsche Krankheit. Hippokrates, Stuttgart, pp 25–41

go back to reference Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW (1995) Comparison of executive and visuospatial memory function in Huntington’s disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 58(5):598–606PubMedPubMedCentralCrossRef Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW (1995) Comparison of executive and visuospatial memory function in Huntington’s disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 58(5):598–606PubMedPubMedCentralCrossRef

go back to reference Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington’s disease. Brain 119(Pt 5):1633–1645PubMedCrossRef Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington’s disease. Brain 119(Pt 5):1633–1645PubMedCrossRef

go back to reference Lawrence AD, Hodges JR, Rosser AE, Kershaw A, Ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998) Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain 121(Pt 7):1329–1341PubMedCrossRef Lawrence AD, Hodges JR, Rosser AE, Kershaw A, Ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998) Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain 121(Pt 7):1329–1341PubMedCrossRef

go back to reference Lee K, Holley SM, Shobe JL, Chong NC, Cepeda C, Levine MS, Masmanidis SC (2017) Parvalbumin interneurons modulate striatal output and enhance performance during associative learning. Neuron 93(6):1451–1463. doi:10.1016/j.neuron.2017.02.033 PubMedCrossRef Lee K, Holley SM, Shobe JL, Chong NC, Cepeda C, Levine MS, Masmanidis SC (2017) Parvalbumin interneurons modulate striatal output and enhance performance during associative learning. Neuron 93(6):1451–1463. doi:10.​1016/​j.​neuron.​2017.​02.​033 PubMedCrossRef

go back to reference Li S, Li XJ (2006) Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener 1:19. doi:10.1186/1750-1326-1-19 PubMedPubMedCentralCrossRef Li S, Li XJ (2006) Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener 1:19. doi:10.​1186/​1750-1326-1-19 PubMedPubMedCentralCrossRef

go back to reference Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, Li XJ (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington’s disease. J Neurosci 23(17):6956–6964PubMed Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, Li XJ (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington’s disease. J Neurosci 23(17):6956–6964PubMed

go back to reference Lim SA, Kang UJ, McGehee DS (2014) Striatal cholinergic interneuron regulation and circuit effects. Front Synaptic Neurosci 6:22. doi:10.3389/fnsyn.2014.00022 PubMedPubMedCentralCrossRef Lim SA, Kang UJ, McGehee DS (2014) Striatal cholinergic interneuron regulation and circuit effects. Front Synaptic Neurosci 6:22. doi:10.​3389/​fnsyn.​2014.​00022 PubMedPubMedCentralCrossRef

go back to reference Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345(8942):91–95PubMedCrossRef Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345(8942):91–95PubMedCrossRef

go back to reference Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington’s disease mutation. J Neurosci 19(23):10428–10437PubMed Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington’s disease mutation. J Neurosci 19(23):10428–10437PubMed

go back to reference MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, Gray J, Conneally PM, Young A, Penney J et al (1993) Gametic but not somatic instability of CAG repeat length in Huntington’s disease. J Med Genet 30(12):982–986PubMedPubMedCentralCrossRef MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, Gray J, Conneally PM, Young A, Penney J et al (1993) Gametic but not somatic instability of CAG repeat length in Huntington’s disease. J Med Genet 30(12):982–986PubMedPubMedCentralCrossRef

go back to reference Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87(3):493–506PubMedCrossRef Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87(3):493–506PubMedCrossRef

go back to reference Maurice N, Liberge M, Jaouen F, Ztaou S, Hanini M, Camon J, Deisseroth K, Amalric M, Kerkerian-Le Goff L, Beurrier C (2015) Striatal cholinergic interneurons control motor behavior and basal ganglia function in experimental parkinsonism. Cell Rep 13(4):657–666. doi:10.1016/j.celrep.2015.09.034 PubMedCrossRef Maurice N, Liberge M, Jaouen F, Ztaou S, Hanini M, Camon J, Deisseroth K, Amalric M, Kerkerian-Le Goff L, Beurrier C (2015) Striatal cholinergic interneurons control motor behavior and basal ganglia function in experimental parkinsonism. Cell Rep 13(4):657–666. doi:10.​1016/​j.​celrep.​2015.​09.​034 PubMedCrossRef

go back to reference Menalled L, Brunner D (2014) Animal models of Huntington’s disease for translation to the clinic: best practices. Mov Disord 29(11):1375–1390. doi:10.1002/mds.26006 PubMedCrossRef Menalled L, Brunner D (2014) Animal models of Huntington’s disease for translation to the clinic: best practices. Mov Disord 29(11):1375–1390. doi:10.​1002/​mds.​26006 PubMedCrossRef

go back to reference Meng Y, Jiang J, Bachevalier J, Zhang X, Chan AW (2017) Developmental whole brain white matter alterations in transgenic Huntington’s disease monkey. Sci Rep 7(1):379. doi:10.1038/s41598-017-00381-8 PubMedPubMedCentralCrossRef Meng Y, Jiang J, Bachevalier J, Zhang X, Chan AW (2017) Developmental whole brain white matter alterations in transgenic Huntington’s disease monkey. Sci Rep 7(1):379. doi:10.​1038/​s41598-017-00381-8 PubMedPubMedCentralCrossRef

go back to reference Moran S, Chi T, Prucha MS, Ahn KS, Connor-Stroud F, Jean S, Gould K, Chan AW (2015) Germline transmission in transgenic Huntington’s disease monkeys. Theriogenology 84(2):277–285. doi:10.1016/j.theriogenology.2015.03.016 PubMedPubMedCentralCrossRef Moran S, Chi T, Prucha MS, Ahn KS, Connor-Stroud F, Jean S, Gould K, Chan AW (2015) Germline transmission in transgenic Huntington’s disease monkeys. Theriogenology 84(2):277–285. doi:10.​1016/​j.​theriogenology.​2015.​03.​016 PubMedPubMedCentralCrossRef

go back to reference Morton AJ, Howland DS (2013) Large genetic animal models of Huntington’s disease. J Huntingtons Dis 2(1):3–19. doi:10.3233/JHD-130050 PubMed Morton AJ, Howland DS (2013) Large genetic animal models of Huntington’s disease. J Huntingtons Dis 2(1):3–19. doi:10.​3233/​JHD-130050 PubMed

go back to reference Nance MA, Myers RH (2001) Juvenile onset Huntington’s disease–clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7(3):153–157. doi:10.1002/mrdd.1022 PubMedCrossRef Nance MA, Myers RH (2001) Juvenile onset Huntington’s disease–clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7(3):153–157. doi:10.​1002/​mrdd.​1022 PubMedCrossRef

go back to reference Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L, Kang Y, Zhao X, Si W, Li W, Xiang AP, Zhou J, Guo X, Bi Y, Si C, Hu B, Dong G, Wang H, Zhou Z, Li T, Tan T, Pu X, Wang F, Ji S, Zhou Q, Huang X, Ji W, Sha J (2014) Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell. doi:10.1016/j.cell.2014.01.027 Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L, Kang Y, Zhao X, Si W, Li W, Xiang AP, Zhou J, Guo X, Bi Y, Si C, Hu B, Dong G, Wang H, Zhou Z, Li T, Tan T, Pu X, Wang F, Ji S, Zhou Q, Huang X, Ji W, Sha J (2014) Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell. doi:10.​1016/​j.​cell.​2014.​01.​027

go back to reference Niu Y, Guo X, Chen Y, Wang CE, Gao J, Yang W, Kang Y, Si W, Wang H, Yang SH, Li S, Ji W, Li XJ (2015) Early Parkinson’s disease symptoms in alpha-synuclein transgenic monkeys. Hum Mol Genet 24(8):2308–2317. doi:10.1093/hmg/ddu748 PubMedCrossRef Niu Y, Guo X, Chen Y, Wang CE, Gao J, Yang W, Kang Y, Si W, Wang H, Yang SH, Li S, Ji W, Li XJ (2015) Early Parkinson’s disease symptoms in alpha-synuclein transgenic monkeys. Hum Mol Genet 24(8):2308–2317. doi:10.​1093/​hmg/​ddu748 PubMedCrossRef

go back to reference Oakeshott S, Farrar A, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, Ramboz S, Howland D, Brunner D (2013) Deficits in a simple visual go/no-go discrimination task in two mouse models of Huntington’s disease. PLoS Curr. doi:10.1371/currents.hd.fe74c94bdd446a0470f6f905a30b5dd1ecurrents.hd.fe74c94bdd446a0470f6f905a30b5dd1 Oakeshott S, Farrar A, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, Ramboz S, Howland D, Brunner D (2013) Deficits in a simple visual go/no-go discrimination task in two mouse models of Huntington’s disease. PLoS Curr. doi:10.​1371/​currents.​hd.​fe74c94bdd446a04​70f6f905a30b5dd1​ecurrents.​hd.​fe74c94bdd446a04​70f6f905a30b5dd1​

go back to reference Oorschot DE (1996) Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol 366(4):580–599. doi:10.1002/(SICI)1096-9861(19960318)366:4<580:AID-CNE3>3.0.CO;2-0 PubMedCrossRef Oorschot DE (1996) Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol 366(4):580–599. doi:10.​1002/​(SICI)1096-9861(19960318)366:​4<580:​AID-CNE3>3.​0.​CO;2-0 PubMedCrossRef

go back to reference Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R, McDowell B, Turner B (2005) Depression and stages of Huntington’s disease. J Neuropsychiatry Clin Neurosci 17(4):496–502. doi:10.1176/jnp.17.4.496 PubMedCrossRef Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R, McDowell B, Turner B (2005) Depression and stages of Huntington’s disease. J Neuropsychiatry Clin Neurosci 17(4):496–502. doi:10.​1176/​jnp.​17.​4.​496 PubMedCrossRef

go back to reference Paulsen JS, Smith MM, Long JD (2013) Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 84(11):1233–1239. doi:10.1136/jnnp-2013-305114 PubMedPubMedCentralCrossRef Paulsen JS, Smith MM, Long JD (2013) Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 84(11):1233–1239. doi:10.​1136/​jnnp-2013-305114 PubMedPubMedCentralCrossRef

go back to reference Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J (2010) Cognitive and functional decline in Huntington’s disease: dementia criteria revisited. Mov Disord 25(9):1163–1169. doi:10.1002/mds.22953 PubMedPubMedCentralCrossRef Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J (2010) Cognitive and functional decline in Huntington’s disease: dementia criteria revisited. Mov Disord 25(9):1163–1169. doi:10.​1002/​mds.​22953 PubMedPubMedCentralCrossRef

go back to reference Penny GR, Wilson CJ, Kitai ST (1988) Relationship of the axonal and dendritic geometry of spiny projection neurons to the compartmental organization of the neostriatum. J Comp Neurol 269(2):275–289. doi:10.1002/cne.902690211 PubMedCrossRef Penny GR, Wilson CJ, Kitai ST (1988) Relationship of the axonal and dendritic geometry of spiny projection neurons to the compartmental organization of the neostriatum. J Comp Neurol 269(2):275–289. doi:10.​1002/​cne.​902690211 PubMedCrossRef

go back to reference Petryszyn S, Beaulieu JM, Parent A, Parent M (2014) Distribution and morphological characteristics of striatal interneurons expressing calretinin in mice: a comparison with human and nonhuman primates. J Chem Neuroanat 59–60:51–61. doi:10.1016/j.jchemneu.2014.06.002 PubMedCrossRef Petryszyn S, Beaulieu JM, Parent A, Parent M (2014) Distribution and morphological characteristics of striatal interneurons expressing calretinin in mice: a comparison with human and nonhuman primates. J Chem Neuroanat 59–60:51–61. doi:10.​1016/​j.​jchemneu.​2014.​06.​002 PubMedCrossRef

go back to reference Petryszyn S, Parent A, Parent M (2017) The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions. J Neural Transm (Vienna). doi:10.1007/s00702-017-1687-x10.1007/s00702-017-1687-x Petryszyn S, Parent A, Parent M (2017) The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions. J Neural Transm (Vienna). doi:10.​1007/​s00702-017-1687-x10.​1007/​s00702-017-1687-x

go back to reference Pfefferle D, Kazem AJ, Brockhausen RR, Ruiz-Lambides AV, Widdig A (2014) Monkeys spontaneously discriminate their unfamiliar paternal kin under natural conditions using facial cues. Curr Biol 24(15):1806–1810. doi:10.1016/j.cub.2014.06.058S0960-9822(14)00774-X PubMedPubMedCentralCrossRef Pfefferle D, Kazem AJ, Brockhausen RR, Ruiz-Lambides AV, Widdig A (2014) Monkeys spontaneously discriminate their unfamiliar paternal kin under natural conditions using facial cues. Curr Biol 24(15):1806–1810. doi:10.​1016/​j.​cub.​2014.​06.​058S0960-9822(14)00774-X PubMedPubMedCentralCrossRef

go back to reference Philips T, Rothstein JD, Pouladi MA (2014) Preclinical models: needed in translation? A Pro/Con debate. Mov Disord 29(11):1391–1396. doi:10.1002/mds.26010 PubMedCrossRef Philips T, Rothstein JD, Pouladi MA (2014) Preclinical models: needed in translation? A Pro/Con debate. Mov Disord 29(11):1391–1396. doi:10.​1002/​mds.​26010 PubMedCrossRef

go back to reference Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington’s disease. Nat Rev Neurosci 14(10):708–721. doi:10.1038/nrn3570nrn3570 PubMedCrossRef Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington’s disease. Nat Rev Neurosci 14(10):708–721. doi:10.​1038/​nrn3570nrn3570 PubMedCrossRef

go back to reference Preisig DF, Kulic L, Kruger M, Wirth F, McAfoose J, Spani C, Gantenbein P, Derungs R, Nitsch RM, Welt T (2016) High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders. Behav Brain Res 311:340–353. doi:10.1016/j.bbr.2016.04.044 PubMedCrossRef Preisig DF, Kulic L, Kruger M, Wirth F, McAfoose J, Spani C, Gantenbein P, Derungs R, Nitsch RM, Welt T (2016) High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders. Behav Brain Res 311:340–353. doi:10.​1016/​j.​bbr.​2016.​04.​044 PubMedCrossRef

go back to reference Putkhao K, Kocerha J, Cho IK, Yang J, Parnpai R, Chan AW (2013) Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington’s disease. Stem Cells Dev 22(8):1198–1205. doi:10.1089/scd.2012.0469 PubMedCrossRef Putkhao K, Kocerha J, Cho IK, Yang J, Parnpai R, Chan AW (2013) Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington’s disease. Stem Cells Dev 22(8):1198–1205. doi:10.​1089/​scd.​2012.​0469 PubMedCrossRef

go back to reference Raper J, Wilson M, Sanchez M, Machado CJ, Bachevalier J (2013) Pervasive alterations of emotional and neuroendocrine responses to an acute stressor after neonatal amygdala lesions in rhesus monkeys. Psychoneuroendocrinology 38(7):1021–1035. doi:10.1016/j.psyneuen.2012.10.008 PubMedCrossRef Raper J, Wilson M, Sanchez M, Machado CJ, Bachevalier J (2013) Pervasive alterations of emotional and neuroendocrine responses to an acute stressor after neonatal amygdala lesions in rhesus monkeys. Psychoneuroendocrinology 38(7):1021–1035. doi:10.​1016/​j.​psyneuen.​2012.​10.​008 PubMedCrossRef

go back to reference Raper J, Bosinger S, Johnson Z, Tharp G, Moran SP, Chan AW (2016) Increased irritability, anxiety, and immune reactivity in transgenic Huntington’s disease monkeys. Brain Behav Immun 58:181–190. doi:10.1016/j.bbi.2016.07.004 PubMedPubMedCentralCrossRef Raper J, Bosinger S, Johnson Z, Tharp G, Moran SP, Chan AW (2016) Increased irritability, anxiety, and immune reactivity in transgenic Huntington’s disease monkeys. Brain Behav Immun 58:181–190. doi:10.​1016/​j.​bbi.​2016.​07.​004 PubMedPubMedCentralCrossRef

go back to reference Ribai P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dode C, Brice A, Durr A (2007) Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol 64(6):813–819. doi:10.1001/archneur.64.6.813 PubMedCrossRef Ribai P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dode C, Brice A, Durr A (2007) Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol 64(6):813–819. doi:10.​1001/​archneur.​64.​6.​813 PubMedCrossRef

go back to reference Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5(1):40. doi:10.1186/1750-1172-5-40 PubMedPubMedCentralCrossRef Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5(1):40. doi:10.​1186/​1750-1172-5-40 PubMedPubMedCentralCrossRef

go back to reference Roseberry TK, Lee AM, Lalive AL, Wilbrecht L, Bonci A, Kreitzer AC (2016) Cell-type-specific control of brainstem locomotor circuits by basal ganglia. Cell 164(3):526–537. doi:10.1016/j.cell.2015.12.037S0092-8674(15)01701-8 PubMedPubMedCentralCrossRef Roseberry TK, Lee AM, Lalive AL, Wilbrecht L, Bonci A, Kreitzer AC (2016) Cell-type-specific control of brainstem locomotor circuits by basal ganglia. Cell 164(3):526–537. doi:10.​1016/​j.​cell.​2015.​12.​037S0092-8674(15)01701-8 PubMedPubMedCentralCrossRef

go back to reference Ross CA (2004) Huntington’s disease: new paths to pathogenesis. Cell 118(1):4–7. doi:10.1016/j.cell.2004.06.022 PubMedCrossRef Ross CA (2004) Huntington’s disease: new paths to pathogenesis. Cell 118(1):4–7. doi:10.​1016/​j.​cell.​2004.​06.​022 PubMedCrossRef

go back to reference Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10(4):204–216. doi:10.1038/nrneurol.2014.24nrneurol.2014.24 PubMedCrossRef Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10(4):204–216. doi:10.​1038/​nrneurol.​2014.​24nrneurol.​2014.​24 PubMedCrossRef

go back to reference Rowell TE, Hinde RA (1962) Vocal communication by the rhesus monkey (Macaca mulatta). Proc Zool Soc Lond 138:279–294CrossRef Rowell TE, Hinde RA (1962) Vocal communication by the rhesus monkey (Macaca mulatta). Proc Zool Soc Lond 138:279–294CrossRef

go back to reference Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, Paulson HL, Bohl J, von Gall C, Vonsattel JP, Korf HW, den Dunnen WF (2013) Degeneration of the cerebellum in Huntington’s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23(2):165–177. doi:10.1111/j.1750-3639.2012.00629.x PubMedCrossRef Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, Paulson HL, Bohl J, von Gall C, Vonsattel JP, Korf HW, den Dunnen WF (2013) Degeneration of the cerebellum in Huntington’s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23(2):165–177. doi:10.​1111/​j.​1750-3639.​2012.​00629.​x PubMedCrossRef

go back to reference Rub U, Seidel K, Vonsattel JP, Lange HW, Eisenmenger W, Gotz M, Del Turco D, Bouzrou M, Korf HW, Heinsen H (2015) Huntington’s disease (HD): neurodegeneration of Brodmann’s primary visual area 17 (BA17). Brain Pathol 25(6):701–711. doi:10.1111/bpa.12237 PubMedCrossRef Rub U, Seidel K, Vonsattel JP, Lange HW, Eisenmenger W, Gotz M, Del Turco D, Bouzrou M, Korf HW, Heinsen H (2015) Huntington’s disease (HD): neurodegeneration of Brodmann’s primary visual area 17 (BA17). Brain Pathol 25(6):701–711. doi:10.​1111/​bpa.​12237 PubMedCrossRef

go back to reference Rub U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW (2016) Huntington’s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol 26(6):726–740. doi:10.1111/bpa.12426 PubMedCrossRef Rub U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW (2016) Huntington’s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol 26(6):726–740. doi:10.​1111/​bpa.​12426 PubMedCrossRef

go back to reference Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntingtin localization in brains of normal and Huntington’s disease patients. Ann Neurol 42(4):604–612. doi:10.1002/ana.410420411 PubMedCrossRef Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntingtin localization in brains of normal and Huntington’s disease patients. Ann Neurol 42(4):604–612. doi:10.​1002/​ana.​410420411 PubMedCrossRef

go back to reference Sato F, Parent A (1998) Efferent projections of single neurons in the external segment of the globus pallidus in monkeys. Neurosci Res 31(1):S173CrossRef Sato F, Parent A (1998) Efferent projections of single neurons in the external segment of the globus pallidus in monkeys. Neurosci Res 31(1):S173CrossRef

go back to reference Saydoff JA, Garcia RA, Browne SE, Liu L, Sheng J, Brenneman D, Hu Z, Cardin S, Gonzalez A, von Borstel RW, Gregorio J, Burr H, Beal MF (2006) Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington’s disease. Neurobiol Dis 24(3):455–465. doi:10.1016/j.nbd.2006.08.011 PubMedCrossRef Saydoff JA, Garcia RA, Browne SE, Liu L, Sheng J, Brenneman D, Hu Z, Cardin S, Gonzalez A, von Borstel RW, Gregorio J, Burr H, Beal MF (2006) Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington’s disease. Neurobiol Dis 24(3):455–465. doi:10.​1016/​j.​nbd.​2006.​08.​011 PubMedCrossRef

go back to reference Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8(3):397–407PubMedCrossRef Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8(3):397–407PubMedCrossRef

go back to reference Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E (1984) Increased rate of suicide among patients with Huntington’s disease. J Neurol Neurosurg Psychiatry 47(12):1283–1287PubMedPubMedCentralCrossRef Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E (1984) Increased rate of suicide among patients with Huntington’s disease. J Neurol Neurosurg Psychiatry 47(12):1283–1287PubMedPubMedCentralCrossRef

go back to reference Selemon LD, Goldman-Rakic PS (1985) Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 5(3):776–794PubMed Selemon LD, Goldman-Rakic PS (1985) Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 5(3):776–794PubMed

go back to reference Shannon KM, Fraint A (2015) Therapeutic advances in Huntington’s disease. Mov Disord 30(11):1539–1546. doi:10.1002/mds.26331 PubMedCrossRef Shannon KM, Fraint A (2015) Therapeutic advances in Huntington’s disease. Mov Disord 30(11):1539–1546. doi:10.​1002/​mds.​26331 PubMedCrossRef

go back to reference Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DM (1999) Huntington’s disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol 156(1):92–99. doi:10.1006/exnr.1998.7005 PubMedCrossRef Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DM (1999) Huntington’s disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol 156(1):92–99. doi:10.​1006/​exnr.​1998.​7005 PubMedCrossRef

go back to reference Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, Deng Y, Pearson J, Vaid K, Bissada N, Wetzel R, Leavitt BR, Hayden MR (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci USA 102(32):11402–11407. doi:10.1073/pnas.0503634102 PubMedPubMedCentralCrossRef Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, Deng Y, Pearson J, Vaid K, Bissada N, Wetzel R, Leavitt BR, Hayden MR (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci USA 102(32):11402–11407. doi:10.​1073/​pnas.​0503634102 PubMedPubMedCentralCrossRef

go back to reference Smith Y, Wichmann T, DeLong MR (2014) Corticostriatal and mesocortical dopamine systems: do species differences matter? Nat Rev Neurosci 15(1):63. doi:10.1038/nrn3469-c1nrn3469-c1 PubMedCrossRef Smith Y, Wichmann T, DeLong MR (2014) Corticostriatal and mesocortical dopamine systems: do species differences matter? Nat Rev Neurosci 15(1):63. doi:10.​1038/​nrn3469-c1nrn3469-c1 PubMedCrossRef

go back to reference Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet 4(4):393–397. doi:10.1038/ng0893-393 PubMedCrossRef Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet 4(4):393–397. doi:10.​1038/​ng0893-393 PubMedCrossRef

go back to reference Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, Oakes D, Shoulson I, Penziner E, Paulsen JS (2007) Verbal episodic memory declines prior to diagnosis in Huntington’s disease. Neuropsychologia 45(8):1767–1776. doi:10.1016/j.neuropsychologia.2006.12.015 PubMedPubMedCentralCrossRef Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, Oakes D, Shoulson I, Penziner E, Paulsen JS (2007) Verbal episodic memory declines prior to diagnosis in Huntington’s disease. Neuropsychologia 45(8):1767–1776. doi:10.​1016/​j.​neuropsychologia​.​2006.​12.​015 PubMedPubMedCentralCrossRef

go back to reference Southwell AL, Ko J, Patterson PH (2009) Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington’s disease. J Neurosci 29(43):13589–13602. doi:10.1523/JNEUROSCI.4286-09.2009 PubMedPubMedCentralCrossRef Southwell AL, Ko J, Patterson PH (2009) Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington’s disease. J Neurosci 29(43):13589–13602. doi:10.​1523/​JNEUROSCI.​4286-09.​2009 PubMedPubMedCentralCrossRef

go back to reference Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ (2005) Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington’s disease transgenic mice. J Comp Neurol 490(4):354–370. doi:10.1002/cne.20680 PubMedCrossRef Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ (2005) Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington’s disease transgenic mice. J Comp Neurol 490(4):354–370. doi:10.​1002/​cne.​20680 PubMedCrossRef

go back to reference Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25(1):1–14. doi:10.1037/a0020937 PubMedPubMedCentralCrossRef Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25(1):1–14. doi:10.​1037/​a0020937 PubMedPubMedCentralCrossRef

go back to reference Stout JC, Jones R, Labuschagne I, O’Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, Durr A, Leavitt BR, Roos RA, Langbehn DR, Tabrizi SJ, Frost C (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. J Neurol Neurosurg Psychiatry 83(7):687–694. doi:10.1136/jnnp-2011-301940jnnp-2011-301940 PubMedPubMedCentralCrossRef Stout JC, Jones R, Labuschagne I, O’Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, Durr A, Leavitt BR, Roos RA, Langbehn DR, Tabrizi SJ, Frost C (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. J Neurol Neurosurg Psychiatry 83(7):687–694. doi:10.​1136/​jnnp-2011-301940jnnp-2011-301940 PubMedPubMedCentralCrossRef

go back to reference Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR (2012) Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11(1):42–53. doi:10.1016/S1474-4422(11)70263-0 PubMedCrossRef Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR (2012) Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11(1):42–53. doi:10.​1016/​S1474-4422(11)70263-0 PubMedCrossRef

go back to reference Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637–649. doi:10.1016/S1474-4422(13)70088-7 PubMedCrossRef Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637–649. doi:10.​1016/​S1474-4422(13)70088-7 PubMedCrossRef

go back to reference Tepper JM, Bolam JP (2004) Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 14(6):685–692. doi:10.1016/j.conb.2004.10.003 PubMedCrossRef Tepper JM, Bolam JP (2004) Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 14(6):685–692. doi:10.​1016/​j.​conb.​2004.​10.​003 PubMedCrossRef

go back to reference Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS, Craufurd D (2012) Longitudinal evaluation of neuropsychiatric symptoms in Huntington’s disease. J Neuropsychiatry Clin Neurosci 24(1):53–60. doi:10.1176/appi.neuropsych.11030057 PubMedCrossRef Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS, Craufurd D (2012) Longitudinal evaluation of neuropsychiatric symptoms in Huntington’s disease. J Neuropsychiatry Clin Neurosci 24(1):53–60. doi:10.​1176/​appi.​neuropsych.​11030057 PubMedCrossRef

go back to reference Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci USA 97(14):8093–8097. doi:10.1073/pnas.110078997 PubMedPubMedCentralCrossRef Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci USA 97(14):8093–8097. doi:10.​1073/​pnas.​110078997 PubMedPubMedCentralCrossRef

go back to reference Vaccarino AL, Sills T, Anderson KE, Borowsky B, Craufurd D, Giuliano J, Goodman L, Guttman M, Kupchak P, Ho AK, Paulsen JS, van Kammen DP, Evans K (2011) Assessment of cognitive symptoms in prodromal and early huntington disease. PLoS Curr 3:RRN1250. doi:10.1371/currents.RRN1250 PubMedPubMedCentral Vaccarino AL, Sills T, Anderson KE, Borowsky B, Craufurd D, Giuliano J, Goodman L, Guttman M, Kupchak P, Ho AK, Paulsen JS, van Kammen DP, Evans K (2011) Assessment of cognitive symptoms in prodromal and early huntington disease. PLoS Curr 3:RRN1250. doi:10.​1371/​currents.​RRN1250 PubMedPubMedCentral

go back to reference Van den Stock J, De Winter FL, Ahmad R, Sunaert S, Van Laere K, Vandenberghe W, Vandenbulcke M (2015) Functional brain changes underlying irritability in premanifest Huntington’s disease. Hum Brain Mapp 36(7):2681–2690. doi:10.1002/hbm.22799 PubMedCrossRef Van den Stock J, De Winter FL, Ahmad R, Sunaert S, Van Laere K, Vandenberghe W, Vandenbulcke M (2015) Functional brain changes underlying irritability in premanifest Huntington’s disease. Hum Brain Mapp 36(7):2681–2690. doi:10.​1002/​hbm.​22799 PubMedCrossRef

go back to reference van Dijk JG, van der Velde EA, Roos RA, Bruyn GW (1986) Juvenile Huntington disease. Hum Genet 73(3):235–239PubMedCrossRef van Dijk JG, van der Velde EA, Roos RA, Bruyn GW (1986) Juvenile Huntington disease. Hum Genet 73(3):235–239PubMedCrossRef

go back to reference Vassos E, Panas M, Kladi A, Vassilopoulos D (2007) Higher levels of extroverted hostility detected in gene carriers at risk for Huntington’s disease. Biol Psychiatry 62(12):1347–1352. doi:10.1016/j.biopsych.2006.12.016 PubMedCrossRef Vassos E, Panas M, Kladi A, Vassilopoulos D (2007) Higher levels of extroverted hostility detected in gene carriers at risk for Huntington’s disease. Biol Psychiatry 62(12):1347–1352. doi:10.​1016/​j.​biopsych.​2006.​12.​016 PubMedCrossRef

go back to reference Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115(1):55–69. doi:10.1007/s00401-007-0306-6 PubMedCrossRef Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115(1):55–69. doi:10.​1007/​s00401-007-0306-6 PubMedCrossRef

go back to reference Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57(5):369–384PubMedCrossRef Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57(5):369–384PubMedCrossRef

go back to reference Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44(6):559–577PubMedCrossRef Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44(6):559–577PubMedCrossRef

go back to reference Wade A, Jacobs P, Morton AJ (2008) Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington’s disease mutation. Brain Res 1188:61–68. doi:10.1016/j.brainres.2007.06.059 PubMedCrossRef Wade A, Jacobs P, Morton AJ (2008) Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington’s disease mutation. Brain Res 1188:61–68. doi:10.​1016/​j.​brainres.​2007.​06.​059 PubMedCrossRef

go back to reference Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50(3):443–452. doi:10.1016/j.neuron.2006.04.010 PubMedCrossRef Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50(3):443–452. doi:10.​1016/​j.​neuron.​2006.​04.​010 PubMedCrossRef

go back to reference Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ (2008) Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington’s disease. Hum Mol Genet 17(17):2738–2751. doi:10.1093/hmg/ddn175 PubMedPubMedCentralCrossRef Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ (2008) Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington’s disease. Hum Mol Genet 17(17):2738–2751. doi:10.​1093/​hmg/​ddn175 PubMedPubMedCentralCrossRef

go back to reference Watson KK, Platt ML (2012) Of mice and monkeys: using non-human primate models to bridge mouse- and human-based investigations of autism spectrum disorders. J Neurodev Disord 4(1):21. doi:10.1186/1866-1955-4-21 PubMedPubMedCentralCrossRef Watson KK, Platt ML (2012) Of mice and monkeys: using non-human primate models to bridge mouse- and human-based investigations of autism spectrum disorders. J Neurodev Disord 4(1):21. doi:10.​1186/​1866-1955-4-21 PubMedPubMedCentralCrossRef

go back to reference Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, Li XJ, Li SH, Yi H, Vonsattel JP, Gusella JF, Hersch S, Auerbach W, Joyner AL, MacDonald ME (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9(4):503–513PubMedCrossRef Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, Li XJ, Li SH, Yi H, Vonsattel JP, Gusella JF, Hersch S, Auerbach W, Joyner AL, MacDonald ME (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9(4):503–513PubMedCrossRef

go back to reference Wild EJ, Tabrizi SJ (2014) Targets for future clinical trials in Huntington’s disease: what’s in the pipeline? Mov Disord 29(11):1434–1445. doi:10.1002/mds.26007 PubMedCrossRef Wild EJ, Tabrizi SJ (2014) Targets for future clinical trials in Huntington’s disease: what’s in the pipeline? Mov Disord 29(11):1434–1445. doi:10.​1002/​mds.​26007 PubMedCrossRef

go back to reference Wu Y, Parent A (2000) Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human. Brain Res 863(1–2):182–191PubMedCrossRef Wu Y, Parent A (2000) Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human. Brain Res 863(1–2):182–191PubMedCrossRef

go back to reference Xu M, Li L, Pittenger C (2016) Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming. Neuroscience 324:321–329. doi:10.1016/j.neuroscience.2016.02.074 PubMedPubMedCentralCrossRef Xu M, Li L, Pittenger C (2016) Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming. Neuroscience 324:321–329. doi:10.​1016/​j.​neuroscience.​2016.​02.​074 PubMedPubMedCentralCrossRef

go back to reference Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW (2008) Towards a transgenic model of Huntington’s disease in a non-human primate. Nature 453(7197):921–924. doi:10.1038/nature06975nature06975 PubMedPubMedCentralCrossRef Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW (2008) Towards a transgenic model of Huntington’s disease in a non-human primate. Nature 453(7197):921–924. doi:10.​1038/​nature06975natur​e06975 PubMedPubMedCentralCrossRef

go back to reference Yeterian EH, Van Hoesen GW (1978) Cortico-striate projections in the rhesus monkey: the organization of certain cortico-caudate connections. Brain Res 139(1):43–63PubMedCrossRef Yeterian EH, Van Hoesen GW (1978) Cortico-striate projections in the rhesus monkey: the organization of certain cortico-caudate connections. Brain Res 139(1):43–63PubMedCrossRef

go back to reference Yoon G, Kramer J, Zanko A, Guzijan M, Lin S, Foster-Barber A, Boxer AL (2006) Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology 67(7):1265–1267. doi:10.1212/01.wnl.0000238390.86304.4e PubMedCrossRef Yoon G, Kramer J, Zanko A, Guzijan M, Lin S, Foster-Barber A, Boxer AL (2006) Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology 67(7):1265–1267. doi:10.​1212/​01.​wnl.​0000238390.​86304.​4e PubMedCrossRef

go back to reference Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, Sandstrom R, Ma Z, Davis C, Pope BD, Shen Y, Pervouchine DD, Djebali S, Thurman RE, Kaul R, Rynes E, Kirilusha A, Marinov GK, Williams BA, Trout D, Amrhein H, Fisher-Aylor K, Antoshechkin I, DeSalvo G, See LH, Fastuca M, Drenkow J, Zaleski C, Dobin A, Prieto P, Lagarde J, Bussotti G, Tanzer A, Denas O, Li K, Bender MA, Zhang M, Byron R, Groudine MT, McCleary D, Pham L, Ye Z, Kuan S, Edsall L, Wu YC, Rasmussen MD, Bansal MS, Kellis M, Keller CA, Morrissey CS, Mishra T, Jain D, Dogan N, Harris RS, Cayting P, Kawli T, Boyle AP, Euskirchen G, Kundaje A, Lin S, Lin Y, Jansen C, Malladi VS, Cline MS, Erickson DT, Kirkup VM, Learned K, Sloan CA, Rosenbloom KR, Lacerda de Sousa B, Beal K, Pignatelli M, Flicek P, Lian J, Kahveci T, Lee D, Kent WJ, Ramalho Santos M, Herrero J, Notredame C, Johnson A, Vong S, Lee K, Bates D, Neri F, Diegel M, Canfield T, Sabo PJ, Wilken MS, Reh TA, Giste E, Shafer A, Kutyavin T, Haugen E, Dunn D, Reynolds AP, Neph S, Humbert R, Hansen RS, De Bruijn M, Selleri L, Rudensky A, Josefowicz S, Samstein R, Eichler EE, Orkin SH, Levasseur D, Papayannopoulou T, Chang KH, Skoultchi A, Gosh S, Disteche C, Treuting P, Wang Y, Weiss MJ, Blobel GA, Cao X, Zhong S, Wang T, Good PJ, Lowdon RF, Adams LB, Zhou XQ, Pazin MJ, Feingold EA, Wold B, Taylor J, Mortazavi A, Weissman SM, Stamatoyannopoulos JA, Snyder MP, Guigo R, Gingeras TR, Gilbert DM, Hardison RC, Beer MA, Ren B (2014) A comparative encyclopedia of DNA elements in the mouse genome. Nature 515 (7527):355–364. doi:10.1038/nature13992 Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, Sandstrom R, Ma Z, Davis C, Pope BD, Shen Y, Pervouchine DD, Djebali S, Thurman RE, Kaul R, Rynes E, Kirilusha A, Marinov GK, Williams BA, Trout D, Amrhein H, Fisher-Aylor K, Antoshechkin I, DeSalvo G, See LH, Fastuca M, Drenkow J, Zaleski C, Dobin A, Prieto P, Lagarde J, Bussotti G, Tanzer A, Denas O, Li K, Bender MA, Zhang M, Byron R, Groudine MT, McCleary D, Pham L, Ye Z, Kuan S, Edsall L, Wu YC, Rasmussen MD, Bansal MS, Kellis M, Keller CA, Morrissey CS, Mishra T, Jain D, Dogan N, Harris RS, Cayting P, Kawli T, Boyle AP, Euskirchen G, Kundaje A, Lin S, Lin Y, Jansen C, Malladi VS, Cline MS, Erickson DT, Kirkup VM, Learned K, Sloan CA, Rosenbloom KR, Lacerda de Sousa B, Beal K, Pignatelli M, Flicek P, Lian J, Kahveci T, Lee D, Kent WJ, Ramalho Santos M, Herrero J, Notredame C, Johnson A, Vong S, Lee K, Bates D, Neri F, Diegel M, Canfield T, Sabo PJ, Wilken MS, Reh TA, Giste E, Shafer A, Kutyavin T, Haugen E, Dunn D, Reynolds AP, Neph S, Humbert R, Hansen RS, De Bruijn M, Selleri L, Rudensky A, Josefowicz S, Samstein R, Eichler EE, Orkin SH, Levasseur D, Papayannopoulou T, Chang KH, Skoultchi A, Gosh S, Disteche C, Treuting P, Wang Y, Weiss MJ, Blobel GA, Cao X, Zhong S, Wang T, Good PJ, Lowdon RF, Adams LB, Zhou XQ, Pazin MJ, Feingold EA, Wold B, Taylor J, Mortazavi A, Weissman SM, Stamatoyannopoulos JA, Snyder MP, Guigo R, Gingeras TR, Gilbert DM, Hardison RC, Beer MA, Ren B (2014) A comparative encyclopedia of DNA elements in the mouse genome. Nature 515 (7527):355–364. doi:10.​1038/​nature13992

go back to reference Zappacosta B, Monza D, Meoni C, Austoni L, Soliveri P, Gellera C, Alberti R, Mantero M, Penati G, Caraceni T, Girotti F (1996) Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington’s disease. Arch Neurol 53(6):493–497PubMedCrossRef Zappacosta B, Monza D, Meoni C, Austoni L, Soliveri P, Gellera C, Alberti R, Mantero M, Penati G, Caraceni T, Girotti F (1996) Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington’s disease. Arch Neurol 53(6):493–497PubMedCrossRef

go back to reference Zeidler S, Hukema RK, Willemsen R (2015) The quest for targeted therapy in fragile X syndrome. Expert Opin Ther Targets 19(10):1277–1281. doi:10.1517/14728222.2015.1079176 PubMedCrossRef Zeidler S, Hukema RK, Willemsen R (2015) The quest for targeted therapy in fragile X syndrome. Expert Opin Ther Targets 19(10):1277–1281. doi:10.​1517/​14728222.​2015.​1079176 PubMedCrossRef

go back to reference Zizak VS, Filoteo JV, Possin KL, Lucas JA, Rilling LM, Davis JD, Peavy G, Wong A, Salmon DP (2005) The ubiquity of memory retrieval deficits in patients with frontal-striatal dysfunction. Cogn Behav Neurol 18(4):198–205PubMedCrossRef Zizak VS, Filoteo JV, Possin KL, Lucas JA, Rilling LM, Davis JD, Peavy G, Wong A, Salmon DP (2005) The ubiquity of memory retrieval deficits in patients with frontal-striatal dysfunction. Cogn Behav Neurol 18(4):198–205PubMedCrossRef